Putting the brakes on tumorigenesis with snake venom toxins: New molecular insights for cancer drug discovery.

Félix A Urra, Ramiro Araya-Maturana

Seminars in cancer biology 2022 May

filter terms:

Cancer cells exhibit molecular characteristics that confer them different proliferative capacities and survival advantages to adapt to stress conditions, such as deregulation of cellular bioenergetics, genomic instability, ability to promote angiogenesis, invasion, cell dormancy, immune evasion, and cell death resistance. In addition to these hallmarks of cancer, the current cytostatic drugs target the proliferation of malignant cells, being ineffective in metastatic disease. These aspects highlight the need to identify promising therapeutic targets for new generations of anti-cancer drugs. Toxins isolated from snake venoms are a natural source of useful molecular scaffolds to obtain agents with a selective effect on cancer cells. In this article, we discuss the recent advances in the molecular mechanisms of nine classes of snake toxins that suppress the hallmarks of cancer by induction of oxidative phosphorylation dysfunction, reactive oxygen species-dependent DNA damage, blockage of extracellular matrix-integrin signaling, disruption of cytoskeleton network and inhibition of growth factor-dependent signaling. The possible therapeutic implications of toxin-based anti-cancer drug development are also highlighted. Copyright © 2020 Elsevier Ltd. All rights reserved.

Citation

Félix A Urra, Ramiro Araya-Maturana. Putting the brakes on tumorigenesis with snake venom toxins: New molecular insights for cancer drug discovery. Seminars in cancer biology. 2022 May;80:195-204